Vitaccess Real MG Registry
Part of paid clinical trials in Orange, California.
- Sponsor
- Vitaccess Ltd
- Study ID
- NCT06064461
- Status
- Recruiting
Conditions
- Myasthenia Gravis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Key Dates
- Start date
- Jul 31, 2024
- Status verified
- Jul 2025
- Primary completion
- Jul 31, 2034
- Completion
- Jul 31, 2034
Study Design
- Enrollment
- 600 participants (estimated)
Primary Outcome Measure
The Vitaccess Real MG Registry [ Time Frame: 10 years ]
Central Contacts
- Mark JW Larkin, PhD+44 1865818983
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCI Health | Orange | California | 92868 | Ali Habib, MD (PRINCIPAL_INVESTIGATOR) |
| HSHS St. Elizabeth's Hospital | O'Fallon | Illinois | 62269 | Beth J Corbett Raghav Govindarajan, MD (PRINCIPAL_INVESTIGATOR) |
| UK HealthCare - University of Kentucky | Lexington | Kentucky | 40536 | Research Associate Clinical I/UKHC +1 (859) 323-5000 Zabeen Mahuwala, MD (PRINCIPAL_INVESTIGATOR) |
| Neurology Associates of South Jersey | Lumberton | New Jersey | 08048 | Mayank Mathur, MD |
| Medical University South Carolina | Charleston | South Carolina | 29425 | Katherine Ruzhansky, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Thy Nguyen, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Orange, CA
Related Studies
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisPHASE3 · Recruiting · Janssen Research & Development, LLC · Paradise Valley, Arizona
- A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisPHASE2/PHASE3 · Recruiting · Janssen Research & Development, LLC · Phoenix, Arizona
- The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisRecruiting · Ad scientiam · Aurora, Colorado